Sense to Act: An Interoceptive Sensibility Intervention for Musculoskeletal Pain
CompletedNot applicableNCT06285864
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The ability to be connected and act according to bodily information is fundamental in chronic pain adjustment. This study aims to test the feasibility of an intervention designed to improve interoceptive sensibility, i.e., the ability to sense, interpret, and regulate bodily sensations in chronic musculoskeletal pain patients.
Study details
- Official title
- Sense to Act: Pilot Randomized-controlled Trial of an Interoceptive Sensibility Intervention for Musculoskeletal Pain
- Conditions
- Interventions
- Behavioral: Interoception-based intervention
- Sponsor
- Iscte-University Institute of Lisbon
- Collaborators
- Foundation for Science and Technology, Portugal; University of Évora
- Start date
- 2024-02-11
- Primary completion
- 2024-06-20
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Portugal
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult individuals (over 18 years old) * experiencing chronic musculoskeletal pain (≥ 3 months) * able to understand and speak portuguese Exclusion Criteria: * neurodegenerative diseases * cancer pain * recent fractures, or surgeries (\< 3 months).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06285864